Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT06188208 |
Title | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Vividion Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
NEXT Austin | RECRUITING | Austin | Texas | 78758 | United States | Details |
MDACC | RECRUITING | Houston | Texas | 77030 | United States | Details |
NEXT Dallas | RECRUITING | Irving | Texas | 75039 | United States | Details |
NEXT San Antonio | RECRUITING | San Antonio | Texas | 78299 | United States | Details |
NEXT Virginia | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
Cancer Research South Australia | RECRUITING | Adelaide | Australia | Details | ||
ICON Cancer Research | RECRUITING | South Brisbane | Australia | Details |